Testing helps us with two stages of controlling the pandemic. The first is the diagnosis of infected patients via virus-specific molecular tests. The second is identifying recovered patients via immunochromatography (rapid test).
While getting ready for the post-Covid-19 state, we understand the importance of being technologically prepared for the post corona stage and the future pandemics. That’s why we started to develop Sars-Cov-2 specific diagnostic rapid tests and virus-specific anti-human antibody rapid tests, and a standardized screening device.